Edoxaban in elderly patient with morbid obesity and atrial fibrillation: the role of plasma levels evaluation for selecting the appropriate dose

被引：5
作者：
Russo, Vincenzo [1 ]
Rago, Anna [1 ]
Laezza, Nunzia [1 ]
Di Micco, Pierpaolo [2 ]
Giannetti, Laura [1 ]
Atripaldi, Luigi [3 ]
D'Onofrio, Antonio [4 ]
Golino, Paolo [1 ]
Nigro, Gerardo [1 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Monaldi Hosp, Cardiol Unit, Via Leonardo Bianchi 1, Naples 80131, Italy
[2] Buonconsiglio Fatebenefratelli Hosp, Div Internal Med, Naples, Italy
[3] Monaldi Hosp, Chem Biochem Unit, Naples, Italy
[4] Monaldi Hosp, Div Cardiol, Naples, Italy
来源：
MONALDI ARCHIVES FOR CHEST DISEASE | 2020年 / 90卷 / 01期
关键词：
atrial fibrillation; obesity; non-vitamin k oral anticoagulant; plasma levels; edoxaban; elderly; ORAL ANTICOAGULANTS; BODY-WEIGHT; WARFARIN; APIXABAN; SAFETY; DABIGATRAN; EFFICACY; STROKE;
D O I：
10.4081/monaldi.2020.1224
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
We present the case of a 80-year-old man with atrial fibrillation, morbid obesity (weight 123 kg, height 167 cm, BMI 44.1), high clearance of creatinine and pharmacological polytherapy, in which the serial determinations of edoxaban plasma levels help us to choose the appropriate dose.
引用
收藏
页码：110 / 112
页数：3
相关论文
共 15 条
  • [1] Apixaban in a Morbid Obese Patient with Atrial Fibrillation: A Clinical Experience Using the Plasmatic Drug Evaluation
    Russo, Vincenzo
    Paccone, Andrea
    Rago, Anna
    Maddaloni, Valeria
    Iafusco, Dario
    Proietti, Riccardo
    Atripaldi, Umberto
    D'Onofrio, Antonio
    Golino, Paolo
    Nigro, Gerardo
    JOURNAL OF BLOOD MEDICINE, 2020, 11 : 77 - 80
  • [2] Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
    Okumura, Ken
    Akao, Masaharu
    Yoshida, Tetsuro
    Kawata, Masahito
    Okazaki, Osamu
    Akashi, Shintaro
    Eshima, Kenichi
    Tanizawa, Kimihiko
    Fukuzawa, Masayuki
    Hayashi, Takuya
    Akishita, Masahiro
    Lip, Gregory Y. H.
    Yamashita, Takeshi
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18) : 1735 - 1745
  • [3] Optimal Dose of Edoxaban for Very Elderly Atrial Fibrillation Patients at High Risk of Bleeding: The LEDIOS Registry
    Kim, Ju Youn
    Kim, Juwon
    Park, Seung-Jung
    Park, Kyoung-Min
    Han, Sang-Jin
    Kim, Dae Kyeong
    Park, Yae Min
    Lee, Sung Ho
    Park, Jong Sung
    On, Young Keun
    KOREAN CIRCULATION JOURNAL, 2024, 54 (07) : 398 - 406
  • [4] Edoxaban plasma levels in patients with non-valvular atrial fibrillation: Inter and intra-individual variability, correlation with coagulation screening test and renal function
    Testa, Sophie
    Dellanoce, Claudia
    Paoletti, Oriana
    Cancellieri, E.
    Morandini, Rossella
    Tala, Maurizio
    Zambelli, Silvia
    Legnani, Cristina
    THROMBOSIS RESEARCH, 2019, 175 : 61 - 67
  • [5] Comparisons of Edoxaban Versus Warfarin on Levels of Plasma Prothrombin Fragment in Patients With Nonvalvular Atrial Fibrillation
    Tamura, Akira
    Yamamoto, Ena
    Kawano, Yoshiyuki
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 136 : 71 - 75
  • [6] Efficacy and Safety of Low-Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE-AF Trial
    Akao, Masaharu
    Yamashita, Takeshi
    Fukuzawa, Masayuki
    Hayashi, Takuya
    Okumura, Ken
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (03):
  • [7] Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation
    Tops, Laurens F.
    Schalij, Martin J.
    Bax, Jeroen J.
    EUROPEAN HEART JOURNAL, 2010, 31 (05) : 542 - U37
  • [8] Efficacy and Safety of Low-Dose Edoxaban According to Body Weight in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis of the ELDERCARE-AF Trial
    Akao, Masaharu
    Yamashita, Takeshi
    Fukuzawa, Masayuki
    Hayashi, Takuya
    Okumura, Ken
    CIRCULATION, 2023, 148
  • [9] Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
    Suwa, Michihiro
    Nohara, Yuki
    Morii, Isao
    Kino, Masaya
    CIRCULATION REPORTS, 2023, 5 (03) : 80 - 89
  • [10] Measuring apixaban levels in the elderly patient with non-valvular atrial fibrillation
    Nissan, Ran
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 335 : 57 - 58
12